Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Olawale Akinbobola"'
Autor:
Olawale Akinbobola, MPH, Wei Liao, PhD, Meredith A. Ray, PhD, Carrie Fehnel, BBA, Jordan Goss, MA, Talat Qureshi, BS, Andrea Saulsberry, DBA, Kourtney Dortch, BS, Matthew P. Smeltzer, PhD, Raymond U. Osarogiagbon, M.B.B.S, FACP
Publikováno v:
JTO Clinical and Research Reports, Vol 5, Iss 8, Pp 100684- (2024)
Introduction: Early lung cancer detection programs improve surgical resection rates and survival but may skew toward more indolent cancers. Methods: Hypothesizing that differences in stage-stratified survival indicate differences in biological aggres
Externí odkaz:
https://doaj.org/article/5b9fa9011db34291adf8a8673c6ca2c9
Autor:
Matthew P. Smeltzer, PhD, Nicholas R. Faris, MDiv, Carrie Fehnel, BBA, Olawale Akinbobola, MPH, Andrea Saulsberry, MBA, Meghan Meadows-Taylor, PhD, Alicia Pacheco, MHA, Meredith Ray, PhD, Raymond U. Osarogiagbon, M.B.B.S.
Publikováno v:
JTO Clinical and Research Reports, Vol 2, Iss 4, Pp 100161- (2021)
Importance: The International Association for the Study of Lung Cancer (IASLC) has proposed a revision of the residual disease (R-factor) classification, to R0, ‘R-uncertain’, R1 and R2. We previously demonstrated longer survival after surgical r
Externí odkaz:
https://doaj.org/article/0189158f27c8445cbe0621fba1f521fa
Autor:
Meghan B, Meadows-Taylor, Nicholas R, Faris, Matthew P, Smeltzer, Meredith A, Ray, Carrie, Fehnel, Olawale, Akinbobola, Folabi, Ariganjoye, Anita, Patel, Alicia, Pacheco, Anurag, Mehrotra, Roy, Fox, Robert, Optican, Keith, Tonkin, James, Machin, Jeffrey, Wright, Edward T, Robbins, Raymond U, Osarogiagbon
Publikováno v:
Chest. 162:242-255
Lung cancer management guidelines strive to improve outcomes. Theoretically, thorough staging promotes optimal treatment selection. We examined the association between guideline-concordant invasive mediastinal nodal staging, guideline-concordant trea
Autor:
Olawale Akinbobola, Meredith A. Ray, Carrie Fehnel, Andrea Saulsberry, Kourtney Dortch, Matthew Smeltzer, Nicholas R. Faris, Raymond U. Osarogiagbon
Publikováno v:
Journal of Thoracic Oncology.
Autor:
Olawale Akinbobola, Meredith A. Ray, Carrie Fehnel, Andrea Saulsberry, Kourtney Dortch, Anberitha T. Matthews, Nicholas R. Faris, Caroline M. Godfrey, Matthew Smeltzer, Raymond U. Osarogiagbon
Publikováno v:
Cancer Research. 83:4382-4382
Background. Most patients die within 5 years of curative-intent lung cancer surgery Differences in surgical quality and cancer biology drive long-term overall survival (OS) differences after curative-intent resection. From 2009 onward, we implemented
Autor:
Huibo Shao, Yu-Sheng Lee, Carrie Fehnel, Olawale Akinbobola, Andrea Saulsberry, Kourtney Dortch, Anberitha T. Matthews, Nicholas R. Faris, Matthew Smeltzer, Meredith A. Ray, Raymond U. Osarogiagbon
Publikováno v:
Cancer Research. 83:3216-3216
Introduction. Poor quality NSCLC resection impairs survival, but some patients survive irrespective. We explored characteristics of patients in 4 cohorts defined by surgery quality and survival. Methods. We analyzed stage I resections in a population
Autor:
Meredith A. Ray, Carrie Fehnel, Olawale Akinbobola, Andrea Saulsberry, Kourtney Dortch, Anberitha Matthews, Amal Anga, Christopher Giampapa, Elizabeth Sales, Sherry Okun, Edward T. Robbins, Bradley Wolf, Paul Levy, Horace L. Wiggins, Thomas Ng, Vishal Sachdev, Ganpat Valaulikar, Hetal D. Patel, Nicholas R. Faris, Matthew Smeltzer, Raymond U. Osarogiagbon
Publikováno v:
Cancer Research. 83:4359-4359
Introduction. Despite its importance, pathologic nodal (pN) staging of lung cancer remains poor. We evaluated the quality and survival impact of two interventions to improve pN staging. Methods. Using a non-randomized stepped-wedge design, we impleme
Autor:
Huibo Shao, Yu-Sheng Lee, Carrie Fehnel, Olawale Akinbobola, Andrea Saulsberry, Kourtney Dortch, Anberitha T. Matthews, Nicholas R. Faris, Meredith A. Ray, Matthew Smeltzer, Raymond U. Osarogiagbon
Publikováno v:
Cancer Research. 83:4372-4372
Introduction. 5-year disease-free survival after curative-intent resection of stage IA NSCLC approximates 65%. The quality of resection and differences in cancer biology probably account for most curative-intent treatment failure. We evaluated the ha